RECCHIA, FABIO ANASTASIO
 Distribuzione geografica
Continente #
NA - Nord America 13.992
EU - Europa 9.219
AS - Asia 1.919
Continente sconosciuto - Info sul continente non disponibili 84
SA - Sud America 82
OC - Oceania 24
AF - Africa 14
Totale 25.334
Nazione #
US - Stati Uniti d'America 13.750
GB - Regno Unito 3.254
UA - Ucraina 1.247
IT - Italia 1.203
DK - Danimarca 1.118
DE - Germania 947
CN - Cina 649
SG - Singapore 623
VN - Vietnam 443
SE - Svezia 415
RU - Federazione Russa 352
CA - Canada 238
FI - Finlandia 216
IE - Irlanda 193
FR - Francia 117
HK - Hong Kong 104
EU - Europa 84
BR - Brasile 75
PL - Polonia 59
JP - Giappone 33
NL - Olanda 27
IN - India 25
CH - Svizzera 20
AU - Australia 15
BE - Belgio 11
PT - Portogallo 11
RO - Romania 10
NZ - Nuova Zelanda 9
ES - Italia 7
IR - Iran 6
KR - Corea 6
PK - Pakistan 5
IQ - Iraq 4
TR - Turchia 4
GE - Georgia 3
ID - Indonesia 3
LT - Lituania 3
MA - Marocco 3
AO - Angola 2
AR - Argentina 2
CI - Costa d'Avorio 2
EC - Ecuador 2
EG - Egitto 2
NG - Nigeria 2
PH - Filippine 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GA - Gabon 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
MD - Moldavia 1
MX - Messico 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SD - Sudan 1
TH - Thailandia 1
TW - Taiwan 1
UG - Uganda 1
Totale 25.334
Città #
Southend 2.638
Woodbridge 1.900
Ann Arbor 1.698
Chandler 1.253
Houston 1.134
Fairfield 793
San Mateo 790
Dearborn 657
Jacksonville 630
Falls Church 455
Seattle 441
Singapore 436
Cambridge 384
Wilmington 382
Beijing 366
Wayne 330
Ashburn 311
Boardman 260
Dong Ket 255
Stevenage 252
Portsmouth 219
Lawrence 208
Pisa 189
Dublin 174
Ottawa 121
Redwood City 118
Montréal 91
Brooklyn 83
Guangzhou 76
San Diego 70
Old Bridge 69
Santa Clara 55
Warsaw 51
Rome 46
Milan 45
Norwalk 40
London 35
Munich 28
Florence 23
Tokyo 23
Fremont 21
Helsinki 20
Foggia 18
Buti 17
Cascina 17
Caserta 14
Genoa 14
Paris 14
Livorno 13
Selargius 13
Shenzhen 13
Augusta 12
Kunming 12
Los Angeles 12
San Giuliano Terme 12
West Jordan 12
Hanover 11
Provo 10
Washington 10
Nanjing 9
Osaka 9
Salerno 9
São Paulo 9
Chicago 8
Chiswick 8
Islington 8
Lyon 8
Mountain View 8
Philadelphia 8
Traverse City 8
Brussels 7
Freiburg im Breisgau 7
New York 7
Parma 7
Rimini 7
Siena 7
Toronto 7
Ypsilanti 7
Bologna 6
Dongguan 6
Frankfurt am Main 6
Melbourne 6
Naples 6
Nürnberg 6
Padova 6
San Antonio 6
Simi Valley 6
Gdynia 5
New Bedfont 5
Porto Ercole 5
Saint Louis 5
Santa Ana Heights 5
Sarno 5
Sassari 5
Shanghai 5
Turin 5
Assago 4
Auckland 4
Bagnolet 4
Berlin 4
Totale 17.657
Nome #
Magnetic resonance imaging of infarct-induced canonical wingless/integrated (Wnt)/β-catenin/T-cell factor pathway activation, in vivo. 260
3D CMR Mapping of Metabolism by Hyperpolarized 13C-Pyruvate in Ischemia–Reperfusion 212
A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis 198
Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure 189
Surgical Access and Stimulation of the Pig Pudendal Nerve to Restore Bladder Dysfunctions 183
Molecular Advances in Reporter Genes: The Need to Witness the Function of Stem Cells in Failing Heart in Vivo. 182
Multimodal molecular imaging system for pathway-specific reporter gene expression 178
An Implantable ZigBee Ready Telemetric Platform For In Vivo Monitoring Of Physiological Parameters 176
A Dose-Response Elevation in Hepatic Glucose Uptake is Paralleled by Liver Triglyceride Synthesis and Release. 174
DNP methods for cardiac metabolic imaging with hyperpolarized [1-13C]pyruvate large dose injection in pigs 171
Real time cardiac metabolism assessed with hyperpolarized [1-13C] acetate in a large animal model 170
Cardiac adeno-associated virus 9-mediated delivery of nestin-640 prevents myocardial remodeling in a rodent model of post-ischemic heart failure 169
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 165
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs 165
REGIONAL MAPPING OF MYOCARDIAL HIBERNATION PHENOTYPE IN IDIOPATHIC END-STAGE DILATED CARDIOMYOPATHY 163
Proteomics-based network analysis characterizes biological processes and pathways activated by preconditioned mesenchymal stem cells in cardiac repair mechanisms 161
Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5T cardiac MRI in a rat model of myocardial infarction 158
Modulating Fatty Acid Oxidation in Heart Failure 157
Acute vagal stimulation attenuates cardiac metabolic response to beta-adrenergic stress. 154
Cardiovascular Molecular Imaging with Hyperpolarized [1-13C] acetate and [1-13C] pyruvate in middle size animal model 154
Acetylation mediates Cx43 reduction caused by electrical stimulation 154
Enabling MSI-Guided Laser Capture Microdissection 152
Placental stem cells pre-treated with hyaluronan-butyric-retinoic ester to cure infarcted pig hearts: a multimodal study. 150
Glucose-6-Phosphate Dehydrogenase Deficiency Increases Myocardial Redox Stress and Moderately Accelerates the Development of Heart Failure 147
Chronic inhibition of nitric oxide synthase alters cardiac substrate handling: underestimating changes in metabolism. 147
Low HDL - high inflammatory markers in heart failure induced by high frequency pacing in minipigs. 144
Diverse protein kinase A-dependent myofilament protein phosphorylation in the background of regional contractile dysfunction in pacing-induced heart failure 144
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure 143
Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart. 143
Adeno-associated virus mediated gene delivery into coronary microvessels of chronically instrumented dogs. 142
Reduced cardiac NO production during pacing-induced heart failure 141
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. 139
Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs 137
Pathologic pulse pressure in isolated coronary artery bed augments flow in vivo despite constant ventricular workload 137
Systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance. 136
Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. 136
Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure. 136
Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa. 136
Altered cardiac metabolic phenotype after prolonged inhibition of NO synthesis in chronically instrumented dogs. 135
Pathogenic role of mitochondrial calcium uniporter upregulation in the failing heart: Ca2+ mishandling or what else? 135
Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure. 133
In vitro system to study realistic pulsatile flow and stretch signaling in cultured vascular cells 132
Water-Dispersible Three-Dimensional LC-Nanoresonators 132
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. 131
Animal models of dilated cardiomyopathy for translational research. 130
Transthoracic Sensor for Noninvasive Assessment of Left Ventricular Contractility: Validation in A Minipig Model of Chronic Heart Failure. 130
Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. 130
LOW HDL-HIGH INFLAMMATORY MARKERS IN HEART FAILURE INDUCED BY HIGH FREQUENCY PACING IN MINIPIGS 130
Reduced left ventricular compliance and mechanical efficiency after prolonged inhibition of NO synthesis in conscious dogs. 129
Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats. 129
Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart. 129
Nestin is a key regulator of cardioprotection and nestin-640 gene therapy rescues infarcted myocardium 129
Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture 128
Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation. 128
Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. 127
Nitric oxide-mediated arteriolar dilation after endothelial deformation 127
Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion. 127
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. 127
Segmental analysis of cardiac metabolism by hyperpolarized [1-13C] pyruvate: an in-vivo 3D MRI study in pigs 127
Short Interfering RNA-Mediated Knockdown Of Glucose-6-Phosphate Dehydrogenase Impairs Cardiac Contractile Performance and Efficiency in Conscious Dogs. 127
Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. 126
The rate of tension redevelopment is not modulated by sarcomere length in permeabilized human, murine and porcine cardiomyocytes. 126
Evaluation of the expression of transcripts coding for CNP and for its specific receptor NPR-B by Real Time PCR in cardiac tissue of normal and heart failure animals 126
AAV-Mediated Delivery of VEGF-B Preserves Viability and Cardiac Function Following Myocardial Infarction through a Direct Effect on Cardiomyocyte Survival and Contractility 126
Changes in cardiac metabolism produced by acute inhibition of NO synthase can be reversed by a long-acting NO donor 126
Amlodipine releases nitric oxide (NO) from coronary microvessels after pacing induced dilated cardiomyopathy. 126
Altered metabolic response to exercise in the eNOS knockout mice. 126
Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy 126
Acute NO synthase inhibition profoundly alters myocardial oxidation of free fatty acids and glucose in conscious dogs 125
Early detection of acute lung injury uncoupled to hypoxemia in pigs using ultrasound lung comets. 125
Gene Therapy for Heart Failure: New Perspectives 125
Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure. 124
Combined PET and Tagging-MRI reveal altered patterns of regional function and metabolism in ventricular dyssynchrony. 124
Modulation of caveolar trafficking of endothelial cells by diagnostic cardiac ultrasound. 124
Cardiac Metabolism in a Pig Model of Ischemia-Reperfusion by Cardiac Magnetic Resonance with Hyperpolarized 13C-Pyruvate 124
NO METABOLITES ACCUMULATE IN ERYTHROCYTES IN PROPORTION TO CARBON DIOXIDE AND BICARBONATE CONCENTRATION. 123
Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. 123
Stem cells transduction with ferritin as a reporter gene to track their fate by 1.5 Tesla MRI, in the beating heart. 123
CELL-TO-CELL VARIABILITY IN TROPONIN I PHOSPHORYLATION IN A PORCINE MODEL OF PACING-INDUCED HEART FAILURE 123
Increased myocardial glucose oxidation in severe heart failure despite reduced pyruvate dehydrogenase activity 123
Class I histone deacetylase inhibition for the treatment of sustained atrial fibrillation 123
Early long‐term L‐T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats 123
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. 122
A partial knockdown of glucose-6-phosphate dehydrogenase impairs cardiac contractile performance and efficiency, in vivo 122
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications 122
Pacing induced myocardial ischemia in patients with dilated cardiomyopathy. 122
Selective alteration in cardiac glucose oxidation after prolonged inhibition of NO synthesis in conscious dogs 122
Altered patterns of regional myocardial perfusion and metabolism in mechanical dyssynchrony induced by chronic unipolar left ventricular pacing. 121
The activation of glucose 6-phosphate dehydrogenase as a source of substrate for NADPH oxidase in the failing heart 121
Abnormal stress-induced myocardial metabolic changes in patients with dilated cardiomyopathy. 121
Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy 121
Overview of ventilator-induced lung injury mechanisms 120
Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs 120
Nitric oxide metabolites accumulation in erythrocytes is proportional to the bicarbonate concentration. 120
Tumor necrosis factor- and interleukin-6 do not increase during pacing-induced dilated cardiomyopathy. 120
Cytokines are not a requisite part of the pathophysiology leading to cardiac decompensation. 119
Coronary nitric oxide production controls cardiac substrate metabolism during pregnancy in the dog. 119
New therapies for the failing heart: trans-genes versus trans-cells. 119
Pronounced reduction in left-ventricular diastolic compliance, work and mechanical efficiency after prolonged inhibition of nitric oxide synthesis in conscious dogs 119
A novel endothelial mechanism that counteracts arteriolar constriction. 119
Totale 13.864
Categoria #
all - tutte 126.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.810 0 0 0 0 0 451 563 92 312 41 54 297
2020/20214.555 156 651 312 338 433 578 291 197 278 274 433 614
2021/20223.340 170 615 419 278 65 61 315 592 162 323 81 259
2022/20232.877 233 126 48 605 366 469 36 235 481 69 110 99
2023/20241.082 151 66 203 58 65 161 133 31 13 36 42 123
2024/20251.478 79 62 416 237 188 496 0 0 0 0 0 0
Totale 25.508